ArticleEye (London, England)2026

Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study.

Ashish Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.